Does the presence of lung infection impact the efficacy of cystic fibrosis airway gene therapy?

Does the presence of lung infection impact the efficacy of cystic fibrosis airway gene therapy?

Chief Investigator: Dr Alexandra McCarron (Early Career Researcher) Funding Amount : $40,060 Recipient: The University of Adelaide Overview: This project will evaluate a novel treatment for cystic fibrosis (CF), a chronic, progressive,
Plasma activated hydrogel therapy as a novel treatment for paediatric burns

Plasma activated hydrogel therapy as a novel treatment for paediatric burns

Chief Investigator: Dr Ainslie Derrick-Roberts Funding Amount : $99,946 Recipient: University of South Australia Overview: Paediatric burns are common in children under the age of 5. Treatment of burns is complicated by
Using Genetic Models to Tackle Epilepsy

Using Genetic Models to Tackle Epilepsy

Chief Investigator: Associate Professor Cheryl Shoubridge Funding Amount : $93,488 Recipient: The University of Adelaide Overview: Developmental and epileptic encephalopathies (DEE) are a severe form of epilepsy which presents in early childhood.
Establishing a Sudden Infant Death Syndrome (SIDS) biobank

Establishing a Sudden Infant Death Syndrome (SIDS) biobank

Chief Investigator: Professor Leanne Dibbens Funding Amount : $90,000 Recipient: University of South Australia Overview: Approximately 100 babies die from Sudden Infant Death Syndrome (SIDS) in Australia each year. The cause(s) of